ICRS 2018 - Conference Calendar

Displaying One Session

View
Samarkan (Plenary) Special Session

18.2 - Bench to Bedside, Successes and Failures What did we Learn? (ID 857)

Date
Wed, Apr 11, 2018
Time
09:45 - 10:45
Location
Samarkan (Plenary)
Moderators
Extended Abstract (for invited Faculty only) Others

18.2.1 - The ACI/MACI Story: What went Right & What Problems were Overcome? (ID 10283)

Presentation Number
18.2.1
Topic
Others
Lecture Time
09:45 - 10:05
Session Name
18.2 - Bench to Bedside, Successes and Failures What did we Learn? (ID 857)
Corresponding Author
Authors
Disclosure
I have in the past had a consulting relationship with Genzyme, Sanofi and Vericel.
Extended Abstract (for invited Faculty only) New Cartilage Technology

18.2.2 - Promising Technologies & Failed Translation (ID 10298)

Presentation Number
18.2.2
Topic
New Cartilage Technology
Lecture Time
10:05 - 10:25
Session Name
18.2 - Bench to Bedside, Successes and Failures What did we Learn? (ID 857)
Corresponding Author
Authors
Disclosure
GSK, Employee Xintela AB, Board Member CCRM, Board Member SCB, VP & Board Member
Extended Abstract (for invited Faculty only) Others

18.2.3 - From Bench to Bedside: Cartilage Autograft Implant System (ID 10247)

Presentation Number
18.2.3
Topic
Others
Lecture Time
10:25 - 10:45
Session Name
18.2 - Bench to Bedside, Successes and Failures What did we Learn? (ID 857)
Corresponding Author
Authors
Disclosure
All disclosures up-to-date at AAOS.org